|
2025-03-19 |
2025-03-17 |
VP
Vente planifiée
|
Waddill William D.
Administrateur non-exécutif
|
4 000
-23.4%
54,25
217 000 USD
|
4 000
-23.4%
|
54,25
|
217 000 USD
|
|
|
2025-03-14 |
2025-03-13 |
V
Vente
|
MOLINA ARTURO MD
Chief Medical Officer
Dirigeant
|
30 514
-26.7%
55,74
1 700 850 USD
|
30 514
-26.7%
|
55,74
|
1 700 850 USD
|
|
|
2025-03-14 |
2025-03-12 |
V
Vente
|
Ali Asif
Chief Financial Officer
Dirigeant
|
24 903
-28.4%
58,73
1 462 553 USD
|
24 903
-28.4%
|
58,73
|
1 462 553 USD
|
|
|
2025-02-20 |
2025-02-19 |
V
Vente
|
PATEL DINESH V PH D
President and CEO
Administrateur exécutif
|
5 359
-1.0%
38,18
204 607 USD
|
5 359
-1.0%
|
38,18
|
204 607 USD
|
|
|
2024-11-27 |
2024-11-27 |
V
Vente
|
MOLINA ARTURO MD
Chief Medical Officer
Dirigeant
|
16 000
-25.6%
44,83
717 280 USD
|
16 000
-25.6%
|
44,83
|
717 280 USD
|
|
|
2024-11-27 |
2024-11-27 |
V
Vente
|
MOLINA ARTURO MD
Chief Medical Officer
Dirigeant
|
10 000
-17.7%
44,50
445 000 USD
|
10 000
-17.7%
|
44,50
|
445 000 USD
|
|
|
2024-11-27 |
2024-11-26 |
V
Vente
|
MOLINA ARTURO MD
Chief Medical Officer
Dirigeant
|
5 529
-10.6%
45,60
252 122 USD
|
5 529
-10.6%
|
45,60
|
252 122 USD
|
|
|
2024-11-27 |
2024-11-26 |
V
Vente
|
PATEL DINESH V PH D
President and CEO
Administrateur exécutif
|
21 480
-5.0%
46,25
993 450 USD
|
21 480
-5.0%
|
46,25
|
993 450 USD
|
|
|
2024-11-27 |
2024-11-26 |
V
Vente
|
Gupta Suneel
Chief Development Officer
Dirigeant
|
19 191
-6.7%
45,50
873 191 USD
|
19 191
-6.7%
|
45,50
|
873 191 USD
|
|
|
2024-11-27 |
2024-11-25 |
VP
Vente planifiée
|
PATEL DINESH V PH D
President and CEO
Administrateur exécutif
|
78 520
-15.3%
46,96
3 687 299 USD
|
78 520
-15.3%
|
46,96
|
3 687 299 USD
|
|
|
2024-11-27 |
2024-11-25 |
V
Vente
|
Gupta Suneel
Chief Development Officer
Dirigeant
|
103 437
-28.8%
46,04
4 762 239 USD
|
103 437
-28.8%
|
46,04
|
4 762 239 USD
|
|
|
2024-11-19 |
2024-11-15 |
V
Vente
|
MOLINA ARTURO MD
Chief Medical Officer
Dirigeant
|
1 906
-3.9%
40,98
78 108 USD
|
1 906
-3.9%
|
40,98
|
78 108 USD
|
|
|
2024-09-13 |
2024-09-11 |
V
Vente
|
Ali Asif
Chief Financial Officer
Dirigeant
|
12 000
-25.6%
44,47
533 640 USD
|
12 000
-25.6%
|
44,47
|
533 640 USD
|
|
|
2024-09-13 |
2024-09-11 |
V
Vente
|
Ali Asif
Chief Financial Officer
Dirigeant
|
2 203
-5.9%
44,59
98 232 USD
|
2 203
-5.9%
|
44,59
|
98 232 USD
|
|
|
2024-09-12 |
2024-09-10 |
VP
Vente planifiée
|
Waddill William D.
Administrateur non-exécutif
|
8 000
-40.0%
45,00
360 000 USD
|
8 000
-40.0%
|
45,00
|
360 000 USD
|
|
|
2024-07-26 |
2024-07-24 |
VP
Vente planifiée
|
Waddill William D.
Administrateur non-exécutif
|
8 000
-40.0%
40,00
320 000 USD
|
8 000
-40.0%
|
40,00
|
320 000 USD
|
|
|
2024-06-11 |
2024-06-07 |
VP
Vente planifiée
|
PATEL DINESH V PH D
President and CEO
Administrateur exécutif
|
35 000
-6.4%
35,19
1 231 650 USD
|
35 000
-6.4%
|
35,19
|
1 231 650 USD
|
|
|
2024-06-11 |
2024-06-07 |
VP
Vente planifiée
|
Waddill William D.
Administrateur non-exécutif
|
8 000
-40.0%
35,00
280 000 USD
|
8 000
-40.0%
|
35,00
|
280 000 USD
|
|
|
2024-04-19 |
2024-04-18 |
V
Vente
|
Ali Asif
Chief Financial Officer
Dirigeant
|
1 234
-3.2%
25,11
30 986 USD
|
1 234
-3.2%
|
25,11
|
30 986 USD
|
|
|
2024-04-02 |
2024-04-01 |
VP
Vente planifiée
|
PATEL DINESH V PH D
President and CEO
Administrateur exécutif
|
25 000
-4.4%
28,31
707 750 USD
|
25 000
-4.4%
|
28,31
|
707 750 USD
|
|
|
2024-03-01 |
2024-03-01 |
V
Vente
|
Ali Asif
Chief Financial Officer
Dirigeant
|
2 248
-5.5%
32,33
72 678 USD
|
2 248
-5.5%
|
32,33
|
72 678 USD
|
|
|
2024-03-01 |
2024-03-01 |
V
Vente
|
Ali Asif
Chief Financial Officer
Dirigeant
|
12 000
-22.8%
32,22
386 640 USD
|
12 000
-22.8%
|
32,22
|
386 640 USD
|
|
|
2024-03-01 |
2024-03-01 |
VP
Vente planifiée
|
Waddill William D.
Administrateur non-exécutif
|
12 975
-52.0%
31,34
406 637 USD
|
12 975
-52.0%
|
31,34
|
406 637 USD
|
|
|
2024-03-01 |
2024-03-01 |
VP
Vente planifiée
|
PATEL DINESH V PH D
President and CEO
Administrateur exécutif
|
30 000
-5.0%
31,62
948 600 USD
|
30 000
-5.0%
|
31,62
|
948 600 USD
|
|
|
2024-03-01 |
2024-02-29 |
V
Vente
|
Ali Asif
Chief Financial Officer
Dirigeant
|
2 089
-4.9%
31,00
64 759 USD
|
2 089
-4.9%
|
31,00
|
64 759 USD
|
|
|
2024-03-01 |
2024-02-29 |
V
Vente
|
Ali Asif
Chief Financial Officer
Dirigeant
|
7 850
-15.5%
30,61
240 289 USD
|
7 850
-15.5%
|
30,61
|
240 289 USD
|
|
|
2024-01-11 |
2024-01-09 |
VP
Vente planifiée
|
Gupta Suneel
Chief Development Officer
Dirigeant
|
5 000
-2.6%
25,00
125 000 USD
|
5 000
-2.6%
|
25,00
|
125 000 USD
|
|
|
2023-12-15 |
2023-12-13 |
VP
Vente planifiée
|
PATEL DINESH V PH D
President and CEO
Administrateur exécutif
|
75 000
-12.3%
20,08
1 506 000 USD
|
75 000
-12.3%
|
20,08
|
1 506 000 USD
|
|
|
2024-01-04 |
2023-11-15 |
V
Vente
|
MOLINA ARTURO MD
Chief Medical Officer
Dirigeant
|
1 848
-7.6%
16,24
30 012 USD
|
1 848
-7.6%
|
16,24
|
30 012 USD
|
|
|
2021-12-23 |
2021-12-21 |
V
Vente
|
PATEL DINESH V PH D
President and CEO
Administrateur exécutif
|
15 000
-3.0%
32,14
482 171 USD
|
15 000
-3.0%
|
32,14
|
482 171 USD
|
|
|
2021-02-12 |
2021-02-11 |
VP
Vente planifiée
|
Noonberg Sarah B.
Administrateur non-exécutif
|
3 700
-100.0%
25,09
92 833 USD
|
3 700
-100.0%
|
25,09
|
92 833 USD
|
|
|
2021-02-12 |
2021-02-10 |
VP
Vente planifiée
|
Noonberg Sarah B.
Administrateur non-exécutif
|
400
-100.0%
26,04
10 416 USD
|
400
-100.0%
|
26,04
|
10 416 USD
|
|
|
2021-02-12 |
2021-02-10 |
VP
Vente planifiée
|
Noonberg Sarah B.
Administrateur non-exécutif
|
4 300
-91.5%
25,42
109 306 USD
|
4 300
-91.5%
|
25,42
|
109 306 USD
|
|
|
2021-01-20 |
2021-01-19 |
VP
Vente planifiée
|
PATEL DINESH V PH D
President and CEO
Administrateur exécutif
|
24 846
-5.5%
24,60
611 105 USD
|
24 846
-5.5%
|
24,60
|
611 105 USD
|
|
|
2020-08-12 |
2020-08-11 |
VP
Vente planifiée
|
KHOSLA CHAITAN PHD
Administrateur non-exécutif
|
2 499
-100.0%
17,19
42 952 USD
|
2 499
-100.0%
|
17,19
|
42 952 USD
|
|
|
2020-03-12 |
2020-03-12 |
A
Achat
|
SELICK HAROLD E
Administrateur non-exécutif
|
12 000
+362.5%
6,70
80 400 USD
|
12 000
+362.5%
|
6,70
|
80 400 USD
|
|
|
2019-12-03 |
2019-12-03 |
A
Achat
|
PATEL DINESH V PH D
President and CEO
Administrateur exécutif
|
20 000
+5.1%
5,65
113 000 USD
|
20 000
+5.1%
|
5,65
|
113 000 USD
|
|
|
2019-12-03 |
2019-12-03 |
A
Achat
|
PATEL DINESH V PH D
President and CEO
Administrateur exécutif
|
10 000
+2.6%
5,55
55 500 USD
|
10 000
+2.6%
|
5,55
|
55 500 USD
|
|
|
2019-12-03 |
2019-12-03 |
A
Achat
|
Giraudo Bryan
Administrateur non-exécutif
|
8 000
+inf%
5,70
45 620 USD
|
8 000
+inf%
|
5,70
|
45 620 USD
|
|
|
2019-12-03 |
2019-12-03 |
AP
Achat planifié
|
Gupta Suneel
EVP Clinical Operations
Dirigeant
|
30 000
+153.8%
5,13
153 900 USD
|
30 000
+153.8%
|
5,13
|
153 900 USD
|
|
|
2019-12-03 |
2019-12-03 |
A
Achat
|
Kalkofen Donald A.
Chief Financial Officer
Dirigeant
|
562
+91.7%
5,09
2 861 USD
|
562
+91.7%
|
5,09
|
2 861 USD
|
|
|
2019-12-03 |
2019-12-03 |
A
Achat
|
Kalkofen Donald A.
Chief Financial Officer
Dirigeant
|
613
+inf%
5,10
3 126 USD
|
613
+inf%
|
5,10
|
3 126 USD
|
|
|
2019-08-08 |
2019-08-06 |
VP
Vente planifiée
|
PATEL DINESH V PH D
President and CEO
Administrateur exécutif
|
10 792
-2.8%
8,85
95 535 USD
|
10 792
-2.8%
|
8,85
|
95 535 USD
|
|
|
2019-08-08 |
2019-08-06 |
VP
Vente planifiée
|
Liu David Y
Chief Scientific Officer
Dirigeant
|
3 395
-6.4%
8,85
30 044 USD
|
3 395
-6.4%
|
8,85
|
30 044 USD
|
|
|
2019-03-04 |
2019-03-01 |
V
Vente
|
Liu David Y
Chief Scientific Officer
|
810
-1.6%
8,03
6 504 USD
|
810
-1.6%
|
8,03
|
6 504 USD
|
|
|
2019-03-04 |
2019-03-01 |
V
Vente
|
Shames Richard S.
Chief Medical Officer
|
657
-2.0%
8,03
5 276 USD
|
657
-2.0%
|
8,03
|
5 276 USD
|
|
|
2019-03-04 |
2019-03-01 |
V
Vente
|
PATEL DINESH V PH D
President and CEO
Administrateur exécutif
|
2 183
-0.6%
8,03
17 529 USD
|
2 183
-0.6%
|
8,03
|
17 529 USD
|
|
|
2019-02-08 |
2019-02-06 |
V
Vente
|
Shames Richard S.
Chief Medical Officer
Dirigeant
|
2 580
-9.6%
7,71
19 892 USD
|
2 580
-9.6%
|
7,71
|
19 892 USD
|
|
|
2019-02-08 |
2019-02-06 |
V
Vente
|
Shames Richard S.
Chief Medical Officer
Dirigeant
|
198
-0.7%
8,15
1 614 USD
|
198
-0.7%
|
8,15
|
1 614 USD
|
|
|
2019-02-08 |
2019-02-06 |
V
Vente
|
Liu David Y
Chief Scientific Officer
Dirigeant
|
3 821
-9.4%
7,74
29 562 USD
|
3 821
-9.4%
|
7,74
|
29 562 USD
|
|
|
2019-02-08 |
2019-02-06 |
V
Vente
|
PATEL DINESH V PH D
President and CEO
Administrateur exécutif
|
10 132
-2.8%
7,71
78 118 USD
|
10 132
-2.8%
|
7,71
|
78 118 USD
|
|
|
2019-02-08 |
2019-02-06 |
V
Vente
|
PATEL DINESH V PH D
President and CEO
Administrateur exécutif
|
777
-0.2%
8,10
6 292 USD
|
777
-0.2%
|
8,10
|
6 292 USD
|
|
|
2018-05-21 |
2018-05-17 |
V
Vente
|
CANAAN X L.P.
Actionnaire important
|
38 968
-1.8%
6,09
237 358 USD
|
38 968
-1.8%
|
6,09
|
237 358 USD
|
|
|
2018-05-16 |
2018-05-16 |
V
Vente
|
CANAAN X L.P.
Actionnaire important
|
29 441
-1.3%
6,46
190 071 USD
|
29 441
-1.3%
|
6,46
|
190 071 USD
|
|
|
2018-05-16 |
2018-05-15 |
V
Vente
|
CANAAN X L.P.
Actionnaire important
|
57 715
-2.6%
6,48
374 080 USD
|
57 715
-2.6%
|
6,48
|
374 080 USD
|
|
|
2018-05-16 |
2018-05-14 |
V
Vente
|
CANAAN X L.P.
Actionnaire important
|
77 591
-3.3%
6,37
494 224 USD
|
77 591
-3.3%
|
6,37
|
494 224 USD
|
|
|
2018-03-26 |
2018-03-23 |
V
Vente
|
CANAAN X L.P.
Actionnaire important
|
59 950
-2.5%
20,71
1 241 325 USD
|
59 950
-2.5%
|
20,71
|
1 241 325 USD
|
|
|
2018-03-22 |
2018-03-22 |
V
Vente
|
CANAAN X L.P.
Actionnaire important
|
4 759
-0.2%
20,62
98 133 USD
|
4 759
-0.2%
|
20,62
|
98 133 USD
|
|
|
2018-03-22 |
2018-03-21 |
V
Vente
|
CANAAN X L.P.
Actionnaire important
|
17 699
-0.7%
20,61
364 727 USD
|
17 699
-0.7%
|
20,61
|
364 727 USD
|
|
|
2018-03-22 |
2018-03-20 |
V
Vente
|
CANAAN X L.P.
Actionnaire important
|
17 060
-0.7%
20,61
351 538 USD
|
17 060
-0.7%
|
20,61
|
351 538 USD
|
|
|
2018-03-19 |
2018-03-19 |
V
Vente
|
CANAAN X L.P.
Actionnaire important
|
13 439
-0.6%
20,57
276 446 USD
|
13 439
-0.6%
|
20,57
|
276 446 USD
|
|
|
2018-03-19 |
2018-03-16 |
V
Vente
|
CANAAN X L.P.
Actionnaire important
|
6 926
-0.3%
20,51
142 063 USD
|
6 926
-0.3%
|
20,51
|
142 063 USD
|
|
|
2018-03-15 |
2018-03-15 |
V
Vente
|
CANAAN X L.P.
Actionnaire important
|
11 751
-0.5%
20,64
242 521 USD
|
11 751
-0.5%
|
20,64
|
242 521 USD
|
|
|
2018-03-15 |
2018-03-14 |
V
Vente
|
CANAAN X L.P.
Actionnaire important
|
200
-0.0%
20,77
4 154 USD
|
200
-0.0%
|
20,77
|
4 154 USD
|
|
|
2018-03-15 |
2018-03-13 |
V
Vente
|
CANAAN X L.P.
Actionnaire important
|
1 204
-0.0%
20,84
25 094 USD
|
1 204
-0.0%
|
20,84
|
25 094 USD
|
|
|
2018-03-13 |
2018-03-12 |
VP
Vente planifiée
|
Liu David Y
Chief Scientific Officer
|
3 500
-18.9%
21,29
74 500 USD
|
3 500
-18.9%
|
21,29
|
74 500 USD
|
|
|
2018-03-02 |
2018-03-02 |
VP
Vente planifiée
|
Liu David Y
Chief Scientific Officer
|
875
-6.2%
20,00
17 500 USD
|
875
-6.2%
|
20,00
|
17 500 USD
|
|
|
2018-01-17 |
2018-01-16 |
VP
Vente planifiée
|
Liu David Y
Chief Scientific Officer
Dirigeant
|
875
-18.6%
20,00
17 500 USD
|
875
-18.6%
|
20,00
|
17 500 USD
|
|
|
2017-12-27 |
2017-12-22 |
VP
Vente planifiée
|
Shames Richard S.
Chief Medical Officer
|
3 529
-100.0%
20,50
72 345 USD
|
3 529
-100.0%
|
20,50
|
72 345 USD
|
|
|
2017-12-21 |
2017-12-21 |
VP
Vente planifiée
|
PATEL DINESH V PH D
President and CEO
Administrateur exécutif
|
8 210
-4.1%
19,56
160 570 USD
|
8 210
-4.1%
|
19,56
|
160 570 USD
|
|
|
2017-12-20 |
2017-12-20 |
VP
Vente planifiée
|
PATEL DINESH V PH D
President and CEO
Administrateur exécutif
|
1 790
-0.9%
19,55
34 987 USD
|
1 790
-0.9%
|
19,55
|
34 987 USD
|
|
|
2017-12-20 |
2017-12-18 |
VP
Vente planifiée
|
O'Neil Thomas P.
Chief Financial Officer
|
8 000
-100.0%
20,00
160 000 USD
|
8 000
-100.0%
|
20,00
|
160 000 USD
|
|
|
2017-12-20 |
2017-12-18 |
VP
Vente planifiée
|
Liu David Y
Chief Scientific Officer
|
875
-18.6%
20,00
17 500 USD
|
875
-18.6%
|
20,00
|
17 500 USD
|
|
|
2017-12-01 |
2017-11-30 |
VP
Vente planifiée
|
Liu David Y
Chief Scientific Officer
|
875
-18.6%
20,00
17 500 USD
|
875
-18.6%
|
20,00
|
17 500 USD
|
|
|
2017-11-15 |
2017-11-13 |
VP
Vente planifiée
|
Liu David Y
Chief Scientific Officer
|
3 500
-47.8%
16,97
59 381 USD
|
3 500
-47.8%
|
16,97
|
59 381 USD
|
|
